Aaron E. Sosa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Few therapeutic options are available for recurrent/metastatic head and neck cancer when progression occurs after initial chemotherapy. We analyzed retrospectively the efficacy of weekly Paclitaxel(More)
  • 1